Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment - Trial NCT06033274
Access comprehensive clinical trial information for NCT06033274 through Pure Global AI's free database. This phase not specified trial is sponsored by Montefiore Medical Center and is currently Enrolling by invitation. The study focuses on Tricuspid Regurgitation. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Montefiore Medical Center
Timeline & Enrollment
N/A
Oct 05, 2023
Aug 01, 2027
Primary Outcome
Freedom from device-related complications,Reduction in Tricuspid Regurgitation Severity
Summary
The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on
 this topic are scarce. Particularly, little is known about which patients are at greatest
 risk of procedural complications, such as the timing and onset of conduction disturbances
 necessitating permanent pacemaker implantation, and how such patients are managed. On this
 background, the TRIPLACE Registry - an investigator-initiated global multicenter registry -
 is aimed at better understanding the safety and efficacy of orthotopic TTVR.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06033274
Device Trial